Hospitals are freezing M&A deals

The latest stories trending on MedCity News.

Editor's Pick

Top Story Hospitals Are Freezing M&A Deals as Federal Policies Rattle Industry There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration's flurry of new policies and the resulting economic uncertainty. Hospitals are putting off mergers for the time being, though some are forming joint ventures as a defense mechanism against financial uncertainty. Many are instead shedding assets to cope with the current macroeconomic environment. Sponsored Changes in Nurse Staffing Answer Clinician Demands Presented by WhitePress The ongoing nursing shortage facilitates high turnover rates since nurses know they won't have difficulties finding new jobs. In order to retain and attract staff, it's in a facility's best interest to understand what nurses want. Learn More

Featured News

Bringing Patient Data to the Frontlines: Why Interoperability Must Include EMS EMS providers often treat patients without medical history, risking delays, errors, and guesswork. But new national data-sharing frameworks are starting to close that gap, bringing critical records to first responders in real time. Novo Nordisk Notches a Court Win Against Wegovy and Ozempic Compounders A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic are resolved. Consequently, compounding pharmacies must stop making their versions of the metabolic medicines or face FDA enforcement action. The Silent Mental Health Crisis of Climate Change Many of those who survive the loss, devastation, and displacement of an extreme climate event — such as a flood, tornado, drought, or wildfire — experience anxiety, depression, post-traumatic stress disorder (PTSD), and even suicidal thoughts. Similar mental illnesses are often found even when people are indirectly exposed to extreme climate events.

Video   What Should Employers Be Thinking About as They Develop Their Pharmacy Benefit Strategy? For Josh Golden, Capital Rx's senior vice president of strategy, it boils down to one question employers need to be asking themselves: Does my pharmacy benefit manager make more money when I spend more money? Most PBM profit models are tied directly to the price and volume of drugs, he noted.

Sponsored The Top 6 Best Analytics Tools for Health Care Revenue in 2025 Presented by Millennia Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources. Learn More

Resources

MedCity Pivot: What if Pancreatic Cancer Became a Chronic Disease? Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe